As future investigations will focus on integrating mechanistically disparate findings related to endothelial dysfunction and improper AngII and TGFβ signaling, there will be an increasing need to expand and standardize experimental protocols across various laboratories, so as to compare with more confidence data from different drug treatments and mutant mice. Here, TGFB1 is linked to endothelial dysfunction.